Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 Gy) gamma knife radiosurgery

Neurosurgery

Volumn 68, Issue 4, 2011, Pages 921-931

  Elliott, Robert E ^a   Rush, Stephen C ^a   Morsi, Amr ^a   Mehta, Nisha ^a   Spriet, Jeri ^a   Narayana, Ashwatha ^a   Donahue, Bernadine ^a   Parker, Erik C ^a   Golfinos, John G ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

20 Gy; Brain metastases; Local control; Radiosurgery; Whole brain radiation therapy

Indexed keywords

DEXAMETHASONE; PHENOBARBITAL; STEROID;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEATH; DIZZINESS; FEMALE; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION NECROSIS; RETROSPECTIVE STUDY; SEIZURE; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 79952899852     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318208f58e     Document Type: Article

References (50)

1. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann Neurol. 1980;7(6):529-541. (Pubitemid 10018360)
2. Pickren J, Lopez G, Tzukada Y, et al. Brain metastases: an autopsy study. Cancer Treatment Symptoms. 1983;2:295-313. (Pubitemid 14144564)
3. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45(2):427-434. (Pubitemid 29408559)
4. Lock M, Chow E, Pond GR, et al. Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol (R Coll Radiol). 2004;16(5):332-338. (Pubitemid 38967253)
5. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6(1):1-9. (Pubitemid 10103009)
6. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45(7):741-744.
7. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485-1489. (Pubitemid 28507400)
8. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494-500. (Pubitemid 20067825)
9. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483- 2491. (Pubitemid 43854963)
10. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35(1):27-35. (Pubitemid 26137165)
11. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994;28(4):797-802. (Pubitemid 24099860)
12. Gerosa M, Nicolato A, Foroni R, et al. Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J Neurosurg. 2002;97(5)(Suppl): 515-524. (Pubitemid 35424337)
13. Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery. 2003;52(6):1318-1326. (Pubitemid 36666947)
14. Jawahar A, Willis BK, Smith DR, Ampil F, Datta R, Nanda A. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis. Stereotact Funct Neurosurg. 2002;79(3-4):262-271. (Pubitemid 36928777)
15. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol. 2005;28(2):173-179.
16. Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery. 2003;52(5):1066-1073.
17. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005;30(1):18-23. (Pubitemid 41021675)
18. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994;12(3):627-642. (Pubitemid 24079908)
19. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39(6):789-796. (Pubitemid 19150153)
20. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1113-1121.
21. Chen JC, Petrovich Z, O'Day S, et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery. 2000;47(2):268-279.
22. Petrovich Z, Yu C, Giannotta SL, O'Day S, Apuzzo ML. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg. 2002;97(5)(Suppl):499-506. (Pubitemid 35424334)
23. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg. 2002;97(6):1276-1281. (Pubitemid 35424280)
24. Shehata MK, Young B, Reid B, et al. Stereotatic radiosurgery of 468 brain metastases , or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59(1):87-93. (Pubitemid 38501511)
25. Shiau CY, Sneed PK, Shu HK, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys. 1997;37(2):375-383. (Pubitemid 27138722)
26. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD. Analysis of tumor control and toxicity in patients who have survived at leastone year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003;57(2):452-464. (Pubitemid 37040942)
27. Joseph J, Adler JR, Cox RS, Hancock SL. Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol. 1996;14(4):1085-1092. (Pubitemid 26105513)
28. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291-298. (Pubitemid 30236367)
29. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg. 2006;104(6):907-912. (Pubitemid 43824740)
30. Majhail NS, Chander S, Mehta VS, Julka PK, Ganesh T, Rath GK. Factors influencing early complications following Gamma Knife radiosurgery: a prospective study. Stereotact Funct Neurosurg. 2001;76(1):36-46. (Pubitemid 34507704)
31. Donahue BR, Goldberg JD, Golfinos JG, et al. Importance of MR technique for stereotactic radiosurgery. Neuro Oncol. 2003;5(4):268-274. (Pubitemid 37265907)
32. Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys. 1997;39(2):445-454.
33. Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995;37(3):445-453.
34. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665-1672. (Pubitemid 38670323)
35. Chang EL, Selek U, Hassenbusch SJ III, et al. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005;56(5):936-945.
36. DiBiase SJ, Chin LS, Ma L. Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases. Am J Clin Oncol. 2002;25(2):131-134. (Pubitemid 34293064)
37. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037-1044.
38. Chitapanarux I, Goss B, Vongtama R, et al. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J Neurooncol. 2003;61(2):143-149. (Pubitemid 36253660)
39. Shu HK, Sneed PK, Shiau CY, et al. Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases. Cancer J Sci Am. 1996;2(6):335-342.
40. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol. 1998;16(11): 3563-3569. (Pubitemid 28506769)
41. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53(3):519-526. (Pubitemid 34626488)
42. Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68(5):1388-1395. (Pubitemid 47176822)
43. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys.2002;52(2):333-338. (Pubitemid 34172998)
44. Regine WF, Scott C, Murray K, CurranW.Neurocognitive outcome in brainmetastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys. 2001;51(3):711-717.
45. Williams BJ, Suki D, Fox BD, et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg. 2009;111(3): 439-448.
46. Gelblum DY, Lee H, Bilsky M, Pinola C, Longford S, Wallner K. Radiographic findings and morbidity in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 1998;42(2):391-395. (Pubitemid 28502788)
47. Alexander E III, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995;87(1):34-40.
48. Breneman JC, Warnick RE, Albright RE Jr, et al. Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series. Cancer. 1997;79(3):551-557. (Pubitemid 27051781)
49. Chen JC, O'Day S, Morton D, et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Stereotact Funct Neurosurg. 1999;73(1-4):60-63. (Pubitemid 30345000)
50. Kihlstrom L, Karlsson B, Lindquist C. Gamma Knife surgery for cerebral metastases: implications for survival based on 16 years experience. Stereotact Funct Neurosurg. 1993;61(Suppl 1):45-50. (Pubitemid 24032056)